Affiliation: | (1) Department of Animal Science, Obihiro University of Agriculture and Veterinary Medicine, 080-8555 Obihiro, Hokkaido, Japan;(2) Hokkaido Tokachi Area Regional Food Processing Technology Center, 080-2462 Obihiro, Hokkaido, Japan |
Abstract: | Feeding rats beans with resistant starch reduces their serum cholesterol concentration; however, the mechanism by which this occurs is not fully understood. We examined the effects of enzyme-resistant fractions of adzuki (Vigna angularis) and tebou (Phaseolus vulgaris, var.) beans on serum cholesterol and hepatic mRNA in rats. Rats were fed a cholesterol-free diet with 50 g of cellulose powder (CP)/kg, 50 g of an enzyme-resistant fraction of adzuki starch (AS)/kg, or 50 g of an enzyme-resistant fraction of tebou starch (TS)/kg diet for 4 wk. There were no significant differences in body weight, liver weight, and cecum contents among the groups, nor was there a significant difference in food intake among the groups. The levels of serum total cholesterol, VLDL + intermediate density lipoprotein + LDL-cholesterol, and HDL cholesterol in the AS and TS groups were significantly (P<0.05) lower than in the CP group throughout the feeding period. Total hepatic cholesterol in the CP group was significantly (P<0.05) lower than in the AS and TS groups, fecal cholesterol excretion in the TS group was significantly (P<0.05) greater than in the CP and AS groups, and the fecal total bile acid concentrations in the AS and TS groups were significantly (P<0.05) higher than in the CP group. Cecal acetate, propionate, and n-butyrate concentrations in the AS and TS groups were significantly (P<0.05) higher than in the CP group. The level of hepatic scavenger receptor class B1 (SR-B1) mRNA in the TS group was significantly (P<0.05) higher than in the CP group, and the levels of hepatic cholesterol 7α-hydroxylase mRNA in the AS and TS groups were significantly (P<0.05) higher than in the CP group. These results suggest that AS and TS have a serum cholesterol-lowering function due to the enhanced levels of hepatic SR-B1 and cholesterol 7α-hydroxylase mRNA. |